SemaThera

SemaThera

SemaThera

Entreprise en dmarrage dveloppant des inhibiteurs de SEMA 3A Startup company developing SEMA 3A inhibitors / Dr Mike Sapieha HMR, Montreal, Qubec, Canada
Raised
$2.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$2,600,000
Venture capital - 2018
Senju Pharmaceutical AmorChem
Team Size
1–10
Employees
Location
Headquarters
$2,600,000 Venture capital
BetaKit

SemaThera raises $2 million to develop solution for diabetic macular edema

Health Asia